Related Experiment Video
Updated: May 1, 2026

Telomere Length and Telomerase Activity; A Yin and Yang of Cell Senescence
Published on: May 22, 2013
Telomere length analysis in Cushing's syndrome
Anna Aulinas1, María-José Ramírez2, María-José Barahona3
1Endocrinology/Medicine DepartmentsSant Pau Biomedical Research Institute, Hospital de Sant Pau, Universitat Autònoma de Barcelona, Servei d'Endocrinologia, C/Sant Antoni Maria Claret, 167, 08025 Barcelona, SpainDepartment of Genetics and MicrobiologyCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 745), Universitat Autònoma de Barcelona, Bellaterra, Barcelona, SpainEndocrinology DepartmentHospital Universitari Mutua Terrassa, Terrassa, Barcelona, SpainCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 747)ISCIII, Hospital de Sant Pau, Barcelona, SpainEndocrinology DepartmentCenter for Biomedical Network Research on Bioenginnering, Biomaterials and Nanomedicine (CIBER-BBN), Hospital de Sant Pau, Barcelona, Spain aaulinasm@gmail.com.
Telomere length (TL) did not differ between Cushing's syndrome (CS) patients and controls initially. However, active CS patients showed shorter TL than after remission, suggesting hypercortisolism may impact telomere maintenance.
Area of Science:
- Endocrinology
- Genetics
- Aging Research
Background:
- Cushing's syndrome (CS) involves hypercortisolism, linked to increased morbidity and mortality.
- Shorter telomere length (TL) is observed in chronic stress and depression, potentially indicating premature aging.
- This study investigated whether CS is also associated with shorter TL.
Purpose of the Study:
- To compare telomere length (TL) in patients with Cushing's syndrome (CS) against healthy controls.
- To explore the longitudinal changes in TL during active CS and after remission.
- To identify clinical predictors of TL in CS patients.
Main Methods:
- Compared leukocyte TL in 77 CS patients and 77 matched controls using the telomere restriction fragment-Southern technique.
- Conducted longitudinal evaluation of 15 CS patients during active disease and after remission.
- Utilized multiple linear regression analysis with clinical markers to predict TL.
Main Results:
- No significant difference in mean TL was found between CS patients and controls cross-sectionally.
- Longitudinally, active CS patients exhibited shorter TL compared to their post-remission state (P<0.05).
- Age and dyslipidemia negatively predicted TL, while total leukocyte count positively predicted TL.
Conclusions:
- While cross-sectional TL did not differ, longitudinal data indicate active hypercortisolism is associated with shorter TL.
- Preliminary findings suggest hypercortisolism may negatively affect telomere maintenance.
- Larger studies are required to validate these observations on hypercortisolism and telomere length.
Related Concept Videos
Cushing Syndrome I: Introduction
Cushing Syndrome II: Pathophysiology
Replicative Cell Senescence
Huntington Disease l: Introduction
Telomeres and Telomerase

